AK Medical Holdings logo

1789 - AK Medical Holdings Share Price

HK$20.7 0.8  3.8%

Last Trade - 18/09/20

Sector
Healthcare
Size
Mid Cap
Market Cap £2.29bn
Enterprise Value £2.20bn
Revenue £110.3m
Position in Universe 447th / 5985
Bullish
Bearish
Unlock 1789 Revenue
Momentum
Relative Strength (%)
1m +5.56%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -25.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
148.3 206.2 270.8 372.7 600.6 926.7 1,162 1,639 +44.3%
+25.5 +19.1 +34.7 -0.4 +82.4 +23.3 +39.5
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, AK Medical Holdings Ltd revenues increased 9% to RMB479M. Net income increased 26% to RMB162.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Selling/General/Admin. Expense decrease of 26% to RMB62.8M (expense), General and administrative expenses decrease of 20% to RMB38.3M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 1789
Graphical History

Revenue

1789 Revenue Unlock 1789 Revenue

Net Income

1789 Net Income Unlock 1789 Revenue

Normalised EPS

1789 Normalised EPS Unlock 1789 Revenue

PE Ratio Range

1789 PE Ratio Range Unlock 1789 Revenue

Dividend Yield Range

1789 Dividend Yield Range Unlock 1789 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
1789 EPS Forecasts Unlock 1789 Revenue
Profile Summary

AK MEDICAL HOLDINGS LIMITED is a company principally engaged in the design, development, manufacture and distribution of orthopedic implants. The Company has commercialized the application of three dimensional (3D) printing technology in orthopedic joint and spine replacement implants, with a focus on hip and knee replacement implants. The Company’s 3D Accurate Construction Technology (ACT) solutions assist surgeons in simulating and planning for implant surgeries, simplify surgical processes, offer personalized surgical instruments and pre-surgery selected implants and improve patients’ recovery experience significantly. The Company sells its products mainly within the China market and to oversea markets such as United Kingdom.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated July 17, 2015
Public Since December 20, 2017
No. of Shareholders: n/a
No. of Employees: 790
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Hang Seng Composite , Hang Seng Composite Mid & SmallCap , Hang Seng Composite SmallCap ,
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 1,113,975,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
1789 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 1789
Upcoming Events for 1789
Frequently Asked Questions for AK Medical Holdings
What is the AK Medical Holdings share price?

As of 18/09/20, shares in AK Medical Holdings are trading at HK$20.7, giving the company a market capitalisation of £2.29bn. This share price information is delayed by 15 minutes.

How has the AK Medical Holdings share price performed this year?

Shares in AK Medical Holdings are currently trading at HK$20.7 and the price has moved by 0.163k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the AK Medical Holdings price has moved by 0.162k% over the past year.

What are the analyst and broker recommendations for AK Medical Holdings?

Of the analysts with advisory recommendations for AK Medical Holdings, there are there are currently 2 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for AK Medical Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will AK Medical Holdings next release its financial results?

AK Medical Holdings is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the AK Medical Holdings dividend yield?

The AK Medical Holdings dividend yield is 0.37% based on the trailing twelve month period.

Does AK Medical Holdings pay a dividend?

Last year, AK Medical Holdings paid a total dividend of 0.07, and it currently has a trailing dividend yield of 0.37%. Looking ahead, AK Medical Holdings has not announced an ex-dividend date yet.

When does AK Medical Holdings next pay dividends?

AK Medical Holdings has yet to annouce their ex-dividend date. The historic dividend yield on AK Medical Holdings shares is currently 0.37%.

How do I buy AK Medical Holdings shares?

To buy shares in AK Medical Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of AK Medical Holdings?

Shares in AK Medical Holdings are currently trading at HK$20.7, giving the company a market capitalisation of £2.29bn.

Where are AK Medical Holdings shares listed? Where are AK Medical Holdings shares listed?

Here are the trading details for AK Medical Holdings:

Country of listing: Hong Kong
Exchange: HKG
Ticker Symbol: 1789
What kind of share is AK Medical Holdings?

Based on an overall assessment of its quality, value and momentum, AK Medical Holdings is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a AK Medical Holdings share price forecast 2020?

Shares in AK Medical Holdings are currently priced at HK$20.7. At that level they are trading at 16.54% discount to the analyst consensus target price of 0.00.

Analysts covering AK Medical Holdings currently have a consensus Earnings Per Share (EPS) forecast of 0.311 for the next financial year.

How can I tell whether the AK Medical Holdings share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AK Medical Holdings. Over the past six months, the relative strength of its shares against the market has been -12.95%. At the current price of HK$20.7, shares in AK Medical Holdings are trading at 13.36% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the AK Medical Holdings PE Ratio?

The AK Medical Holdings PE ratio based on its reported earnings over the past 12 months is 64.91. The shares are currently trading at HK$20.7.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of AK Medical Holdings?

AK Medical Holdings's management team is headed by:

Zhijiang Li - CHM
Bin Zhang - SVP
Chaoyang Zhang - SVP
Xiaohong Zhao - CFO
Guowei Wang - NED
Chi Mo Kong - NID
Shu Wing Li - NID
Aiguo Liu - DGM
Caimei Wang - OTH
Zijuan Qi - GMG
Yanshi Sun - OTH
Nannan Wang - OTH
Eric Wang - NID
Hongbo Sun - OTH
Who are the major shareholders of AK Medical Holdings?

Here are the top five shareholders of AK Medical Holdings based on the size of their shareholding:

Ximalaya Ltd Corporation
Percentage owned: 45.35% (505.2m shares)
Hillhouse Capital Advisors, Ltd. Investment Advisor/Hedge Fund
Percentage owned: 6.8% (75.7m shares)
Zhang (Chaoyang) Individual Investor
Percentage owned: 5.28% (58.8m shares)
APG Asset Management N.V. Pension Fund
Percentage owned: 4.45% (49.5m shares)
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund
Percentage owned: 4.43% (49.3m shares)
Similar to 1789
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.